Cargando…
The Impact of Low-Dose Disease-modifying Anti-rheumatics Drugs (DMARDs) on Bone Mineral Density of Premenopausal Women in Early Rheumatoid Arthritis
INTRODUCTION: Rheumatoid arthritis (RA) is a chronic inflammatory disease characterized by symmetrical polyarthritis and multisystemic involvement. OBJECTIVE: The aim of this study was to assess the impact of low dose of methotrexate on bone mineral density (BMD) in patients with early rheumatoid ar...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AVICENA, d.o.o., Sarajevo
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4851528/ https://www.ncbi.nlm.nih.gov/pubmed/27147781 http://dx.doi.org/10.5455/medarh.2016.70.101-103 |
_version_ | 1782429832806662144 |
---|---|
author | Rexhepi, Sylejman Rexhepi, Mjellma Sahatçiu-Meka, Vjollca Mahmutaj, Vigan Boshnjaku, Shkumbin |
author_facet | Rexhepi, Sylejman Rexhepi, Mjellma Sahatçiu-Meka, Vjollca Mahmutaj, Vigan Boshnjaku, Shkumbin |
author_sort | Rexhepi, Sylejman |
collection | PubMed |
description | INTRODUCTION: Rheumatoid arthritis (RA) is a chronic inflammatory disease characterized by symmetrical polyarthritis and multisystemic involvement. OBJECTIVE: The aim of this study was to assess the impact of low dose of methotrexate on bone mineral density (BMD) in patients with early rheumatoid arthritis (RA). MATERIALS AND METHODS: This paper follows a retrospective study, which involves 60 female patients with early onset RA diagnosed according to the American Rheumatism Association Criteria (ACR/EULAR 2010). The patients were divided into two groups group I was composed of thirty patients treated with dose of 7.5 mg/weekly methotrexate (MTX), while group II included thirty patients treated with dose of 2 g/daily sulfasalazine (SSZ). The Disease Activity was measured by a combination of Erythrocyte Sedimentation Rate (ESR) and Disease Activity Score (DAS-28). Bone mineral density of the lumbar spine (L2–4), and femoral neck, was measured by dual energy X-ray absorptiometry (DEXA) (Stratos 800). Laboratory findings included: In this study, we found no negative effect on BMD in RA patients treated with low dose MTX in comparison to patients treated with SSZ. There was not observed significant difference in BMD of the lumbar spine, femur neck or trochanter, of MTX and SSZ patients in the pretreatment phase, nor after 12 months of treatment. No significant change in the biochemical parameters of the both groups. CONCLUSION: Based on the results of our study, low dose of methotrexate has no negative effect on BMD in premenopausal RA patients. We believe that these results might provide new insights and that further longitudinal studies with larger groups of premenopausal RA patients are required. |
format | Online Article Text |
id | pubmed-4851528 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | AVICENA, d.o.o., Sarajevo |
record_format | MEDLINE/PubMed |
spelling | pubmed-48515282016-05-04 The Impact of Low-Dose Disease-modifying Anti-rheumatics Drugs (DMARDs) on Bone Mineral Density of Premenopausal Women in Early Rheumatoid Arthritis Rexhepi, Sylejman Rexhepi, Mjellma Sahatçiu-Meka, Vjollca Mahmutaj, Vigan Boshnjaku, Shkumbin Med Arch Original Paper INTRODUCTION: Rheumatoid arthritis (RA) is a chronic inflammatory disease characterized by symmetrical polyarthritis and multisystemic involvement. OBJECTIVE: The aim of this study was to assess the impact of low dose of methotrexate on bone mineral density (BMD) in patients with early rheumatoid arthritis (RA). MATERIALS AND METHODS: This paper follows a retrospective study, which involves 60 female patients with early onset RA diagnosed according to the American Rheumatism Association Criteria (ACR/EULAR 2010). The patients were divided into two groups group I was composed of thirty patients treated with dose of 7.5 mg/weekly methotrexate (MTX), while group II included thirty patients treated with dose of 2 g/daily sulfasalazine (SSZ). The Disease Activity was measured by a combination of Erythrocyte Sedimentation Rate (ESR) and Disease Activity Score (DAS-28). Bone mineral density of the lumbar spine (L2–4), and femoral neck, was measured by dual energy X-ray absorptiometry (DEXA) (Stratos 800). Laboratory findings included: In this study, we found no negative effect on BMD in RA patients treated with low dose MTX in comparison to patients treated with SSZ. There was not observed significant difference in BMD of the lumbar spine, femur neck or trochanter, of MTX and SSZ patients in the pretreatment phase, nor after 12 months of treatment. No significant change in the biochemical parameters of the both groups. CONCLUSION: Based on the results of our study, low dose of methotrexate has no negative effect on BMD in premenopausal RA patients. We believe that these results might provide new insights and that further longitudinal studies with larger groups of premenopausal RA patients are required. AVICENA, d.o.o., Sarajevo 2016-04 2016-04-01 /pmc/articles/PMC4851528/ /pubmed/27147781 http://dx.doi.org/10.5455/medarh.2016.70.101-103 Text en Copyright: © Sylejman Rexhepi, Mjellma Rexhepi, Vjollca Sahatçiu-Meka, Vigan Mahmutaj, and Shkumbin Boshnjaku http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Paper Rexhepi, Sylejman Rexhepi, Mjellma Sahatçiu-Meka, Vjollca Mahmutaj, Vigan Boshnjaku, Shkumbin The Impact of Low-Dose Disease-modifying Anti-rheumatics Drugs (DMARDs) on Bone Mineral Density of Premenopausal Women in Early Rheumatoid Arthritis |
title | The Impact of Low-Dose Disease-modifying Anti-rheumatics Drugs (DMARDs) on Bone Mineral Density of Premenopausal Women in Early Rheumatoid Arthritis |
title_full | The Impact of Low-Dose Disease-modifying Anti-rheumatics Drugs (DMARDs) on Bone Mineral Density of Premenopausal Women in Early Rheumatoid Arthritis |
title_fullStr | The Impact of Low-Dose Disease-modifying Anti-rheumatics Drugs (DMARDs) on Bone Mineral Density of Premenopausal Women in Early Rheumatoid Arthritis |
title_full_unstemmed | The Impact of Low-Dose Disease-modifying Anti-rheumatics Drugs (DMARDs) on Bone Mineral Density of Premenopausal Women in Early Rheumatoid Arthritis |
title_short | The Impact of Low-Dose Disease-modifying Anti-rheumatics Drugs (DMARDs) on Bone Mineral Density of Premenopausal Women in Early Rheumatoid Arthritis |
title_sort | impact of low-dose disease-modifying anti-rheumatics drugs (dmards) on bone mineral density of premenopausal women in early rheumatoid arthritis |
topic | Original Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4851528/ https://www.ncbi.nlm.nih.gov/pubmed/27147781 http://dx.doi.org/10.5455/medarh.2016.70.101-103 |
work_keys_str_mv | AT rexhepisylejman theimpactoflowdosediseasemodifyingantirheumaticsdrugsdmardsonbonemineraldensityofpremenopausalwomeninearlyrheumatoidarthritis AT rexhepimjellma theimpactoflowdosediseasemodifyingantirheumaticsdrugsdmardsonbonemineraldensityofpremenopausalwomeninearlyrheumatoidarthritis AT sahatciumekavjollca theimpactoflowdosediseasemodifyingantirheumaticsdrugsdmardsonbonemineraldensityofpremenopausalwomeninearlyrheumatoidarthritis AT mahmutajvigan theimpactoflowdosediseasemodifyingantirheumaticsdrugsdmardsonbonemineraldensityofpremenopausalwomeninearlyrheumatoidarthritis AT boshnjakushkumbin theimpactoflowdosediseasemodifyingantirheumaticsdrugsdmardsonbonemineraldensityofpremenopausalwomeninearlyrheumatoidarthritis AT rexhepisylejman impactoflowdosediseasemodifyingantirheumaticsdrugsdmardsonbonemineraldensityofpremenopausalwomeninearlyrheumatoidarthritis AT rexhepimjellma impactoflowdosediseasemodifyingantirheumaticsdrugsdmardsonbonemineraldensityofpremenopausalwomeninearlyrheumatoidarthritis AT sahatciumekavjollca impactoflowdosediseasemodifyingantirheumaticsdrugsdmardsonbonemineraldensityofpremenopausalwomeninearlyrheumatoidarthritis AT mahmutajvigan impactoflowdosediseasemodifyingantirheumaticsdrugsdmardsonbonemineraldensityofpremenopausalwomeninearlyrheumatoidarthritis AT boshnjakushkumbin impactoflowdosediseasemodifyingantirheumaticsdrugsdmardsonbonemineraldensityofpremenopausalwomeninearlyrheumatoidarthritis |